Clinical Trial Update: Effect of Probiotic Formula on Reducing the Risk for Antibiotic-associated Diarrhoea [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating a probiotic formula to reduce the risk of antibiotic-associated diarrhoea, sponsored by Danisco, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibiotic-associated Diarrhoea

Drugs mentioned

• Probiotic Formula

Snippet

Sponsor: Danisco | Conditions: Antibiotic-associated Diarrhoea | Phase 2, Phase 3 | Status: TERMINATED